|
|
Celgene Stock Price CELGCompany Description : A biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. url: www.celgene.com |
Name:
Celgene (MM) |
Symbol:
NASDAQ:CELG |
Stock Market:
NASDAQ Stock Market |
Type:
Common Stock |
ISIN:
|
Description:
|
| | Change (p) | Change (%) | Cur | Bid | Ask | High | Low | Open | Volume | Time | A | |  | -1.8 | -2.49 | 70.45 | 64.58 | 71.4 | 72.4 | 69.03 | 72.4 | 7724808 | 20:00:03 | | |
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD P : - Focalin XR demonstrated better symptom control versus Concerta from 30 minutes to six hours post-dose in primary and secondary endpoints
EAST HANOVER, N.J., July 8 /PRNewswire/ -- A head-to-head study, published in... Celgene News
| Latest Celgene News Headlines | | Date | Time | Source | | | 07/08/2008 | 8:00AM | PRNUS | Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD P |
| 07/01/2008 | 10:50AM | PRNUS | Seven Summits Research Releases Comments on GOOG, ABX, CELG, RF, and BKC |
| 06/20/2008 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on GS, WB, OXY, PCX, and CELG |
| 06/17/2008 | 8:06AM | TFNF | Celgene reports positive results from Vidaza, Revlimid studies |
| 06/16/2008 | 12:18PM | TFNF | Celgene cancer drug shows survival benefit |
| 06/15/2008 | 12:15PM | TFNF | Celgene says revlimid, dexamethasone combination trial shows improved survival |
| 06/13/2008 | 12:35PM | TFNF | Celgene: Vidaza shows 'significant overall survival' benefit in EU study |
| 06/12/2008 | 6:12AM | TFNF | GPC wins European patent for satraplatin in taxane-resistant cancer UPDATE |
| 06/02/2008 | 8:39AM | TFNF | Celgene pulls Revlimid application in Europe |
| 05/21/2008 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on GS, APA, CELG, WAG, and KBH |
| 05/15/2008 | 5:10PM | TFNF | S&P 500 Leaders and Laggards: A CELG |
| 05/08/2008 | 3:44PM | TFNF | Earnings roundup: Celgene, Warner Music Group |
| |
Celgene Company Information| Sector | Turnover (m) | Profit (m) | EPS - Basic | PE ratio | Mkt Cap (m) | NMS | | | 0.00 | 0.00 | | | 0.0 | N/A |
 Register for FREE access to the latest Celgene company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales. |
Latest Celgene Stock Trade| Type | Size | Price | Date | Tr.Time | Units | | | 100 | 70.2 | 07/23/2008 | 7:52PM | USD |
|
|
| |